HIPAY GROUP SA (ALHYP.PA) Fundamental Analysis & Valuation

EPA:ALHYP • FR0012821916

Current stock price

6.1 EUR
-0.18 (-2.87%)
Last:

This ALHYP.PA fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

4

1. ALHYP.PA Profitability Analysis

1.1 Basic Checks

  • ALHYP had positive earnings in the past year.
  • ALHYP had a positive operating cash flow in the past year.
  • The reported net income has been mixed in the past 5 years: ALHYP reported negative net income in multiple years.
  • Each year in the past 5 years ALHYP had a positive operating cash flow.
ALHYP.PA Yearly Net Income VS EBIT VS OCF VS FCFALHYP.PA Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 5M -5M -10M

1.2 Ratios

  • ALHYP has a Return On Assets (2.61%) which is in line with its industry peers.
  • ALHYP has a Return On Equity of 13.62%. This is in the better half of the industry: ALHYP outperforms 71.15% of its industry peers.
  • ALHYP has a better Return On Invested Capital (5.74%) than 69.23% of its industry peers.
Industry RankSector Rank
ROA 2.61%
ROE 13.62%
ROIC 5.74%
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ALHYP.PA Yearly ROA, ROE, ROICALHYP.PA Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 10 -10 -20 -30

1.3 Margins

  • ALHYP has a Profit Margin (7.88%) which is in line with its industry peers.
  • The Operating Margin of ALHYP (6.71%) is comparable to the rest of the industry.
  • ALHYP has a Gross Margin (49.04%) which is comparable to the rest of the industry.
  • ALHYP's Gross Margin has improved in the last couple of years.
Industry RankSector Rank
OM 6.71%
PM (TTM) 7.88%
GM 49.04%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y0.12%
GM growth 5Y1.7%
ALHYP.PA Yearly Profit, Operating, Gross MarginsALHYP.PA Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 20 -20 40 60

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

3

2. ALHYP.PA Health Analysis

2.1 Basic Checks

  • The Return on Invested Capital (ROIC) is below the Cost of Capital (WACC), so ALHYP is destroying value.
  • There is no outstanding debt for ALHYP. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
ALHYP.PA Yearly Shares OutstandingALHYP.PA Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 1M 2M 3M 4M
ALHYP.PA Yearly Total Debt VS Total AssetsALHYP.PA Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 50M 100M 150M

2.2 Solvency

  • ALHYP has an Altman-Z score of 0.36. This is a bad value and indicates that ALHYP is not financially healthy and even has some risk of bankruptcy.
  • With a Altman-Z score value of 0.36, ALHYP is not doing good in the industry: 67.31% of the companies in the same industry are doing better.
  • ALHYP has a Debt/Equity ratio of 0.41. This is a healthy value indicating a solid balance between debt and equity.
  • ALHYP has a Debt to Equity ratio (0.41) which is in line with its industry peers.
Industry RankSector Rank
Debt/Equity 0.41
Debt/FCF N/A
Altman-Z 0.36
ROIC/WACC0.55
WACC10.43%
ALHYP.PA Yearly LT Debt VS Equity VS FCFALHYP.PA Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 20M 40M

2.3 Liquidity

  • ALHYP has a Current Ratio of 1.05. This is a normal value and indicates that ALHYP is financially healthy and should not expect problems in meeting its short term obligations.
  • ALHYP has a Current ratio (1.05) which is in line with its industry peers.
  • ALHYP has a Quick Ratio of 1.05. This is a normal value and indicates that ALHYP is financially healthy and should not expect problems in meeting its short term obligations.
  • ALHYP's Quick ratio of 1.05 is in line compared to the rest of the industry. ALHYP outperforms 44.23% of its industry peers.
Industry RankSector Rank
Current Ratio 1.05
Quick Ratio 1.05
ALHYP.PA Yearly Current Assets VS Current LiabilitesALHYP.PA Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 50M 100M

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

3

3. ALHYP.PA Growth Analysis

3.1 Past

  • The earnings per share for ALHYP have decreased strongly by -20.21% in the last year.
  • The Revenue has been growing slightly by 0.65% in the past year.
  • The Revenue has been growing by 10.34% on average over the past years. This is quite good.
EPS 1Y (TTM)-20.21%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%448.69%
Revenue 1Y (TTM)0.65%
Revenue growth 3Y8.26%
Revenue growth 5Y10.34%
Sales Q2Q%-2.21%

3.2 Future

  • ALHYP is expected to show quite a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 15.47% yearly.
  • ALHYP is expected to show a small growth in Revenue. In the coming years, the Revenue will grow by 3.93% yearly.
EPS Next Y10.26%
EPS Next 2Y15.47%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year4.01%
Revenue Next 2Y3.93%
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

  • The Revenue growth rate is decreasing: in the next years the growth will be less than in the last years.
ALHYP.PA Yearly Revenue VS EstimatesALHYP.PA Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 20M 40M 60M 80M
ALHYP.PA Yearly EPS VS EstimatesALHYP.PA Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2016 2021 2022 2023 2024 2025 2026 2027 0 0.5 -0.5 1 -1 -1.5

More info and screens

Find the best growth stocksShow best growing peers

5

4. ALHYP.PA Valuation Analysis

4.1 Price/Earnings Ratio

  • Based on the Price/Earnings ratio of 6.56, the valuation of ALHYP can be described as very cheap.
  • Based on the Price/Earnings ratio, ALHYP is valued cheaply inside the industry as 90.38% of the companies are valued more expensively.
  • ALHYP is valuated cheaply when we compare the Price/Earnings ratio to 27.42, which is the current average of the S&P500 Index.
  • A Price/Forward Earnings ratio of 13.77 indicates a correct valuation of ALHYP.
  • The rest of the industry has a similar Price/Forward Earnings ratio as ALHYP.
  • ALHYP is valuated rather cheaply when we compare the Price/Forward Earnings ratio to 22.29, which is the current average of the S&P500 Index.
Industry RankSector Rank
PE 6.56
Fwd PE 13.77
ALHYP.PA Price Earnings VS Forward Price EarningsALHYP.PA Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 5 10 15 20 25

4.2 Price Multiples

  • Based on the Enterprise Value to EBITDA ratio, ALHYP is valued a bit cheaper than 71.15% of the companies in the same industry.
Industry RankSector Rank
P/FCF N/A
EV/EBITDA 6.11
ALHYP.PA Per share dataALHYP.PA EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 2 4 6 8 10

4.3 Compensation for Growth

  • ALHYP's low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
  • A more expensive valuation may be justified as ALHYP's earnings are expected to grow with 15.47% in the coming years.
PEG (NY)0.64
PEG (5Y)N/A
EPS Next 2Y15.47%
EPS Next 3YN/A

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

0

5. ALHYP.PA Dividend Analysis

5.1 Amount

  • No dividends for ALHYP!.
Industry RankSector Rank
Dividend Yield 0%

More info and screens

Find the best dividend stocksShow peers with best dividend

ALHYP.PA Fundamentals: All Metrics, Ratios and Statistics

HIPAY GROUP SA

EPA:ALHYP (4/24/2026, 7:00:00 PM)

6.1

-0.18 (-2.87%)

Chartmill FA Rating
GICS SectorFinancials
GICS IndustryGroupFinancial Services
GICS IndustryFinancial Services
Earnings (Last)04-08
Earnings (Next)05-13
Inst Owners0.45%
Inst Owner ChangeN/A
Ins Owners50.11%
Ins Owner ChangeN/A
Market Cap38.49M
Revenue(TTM)74.78M
Net Income(TTM)5.89M
Analysts84.44
Price Target17.34 (184.26%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)0%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)0%
EPS NY rev (3m)-35.82%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)0%
Revenue NY rev (3m)-3.47%
Valuation
Industry RankSector Rank
PE 6.56
Fwd PE 13.77
P/S 0.51
P/FCF N/A
P/OCF 6.2
P/B 0.89
P/tB N/A
EV/EBITDA 6.11
EPS(TTM)0.93
EY15.25%
EPS(NY)0.44
Fwd EY7.26%
FCF(TTM)-0.04
FCFYN/A
OCF(TTM)0.98
OCFY16.14%
SpS11.85
BVpS6.86
TBVpS-0.98
PEG (NY)0.64
PEG (5Y)N/A
Graham Number11.9781 (96.36%)
Profitability
Industry RankSector Rank
ROA 2.61%
ROE 13.62%
ROCE 7.81%
ROIC 5.74%
ROICexc 7.65%
ROICexgc N/A
OM 6.71%
PM (TTM) 7.88%
GM 49.04%
FCFM N/A
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y0.12%
GM growth 5Y1.7%
F-Score4
Asset Turnover0.33
Health
Industry RankSector Rank
Debt/Equity 0.41
Debt/FCF N/A
Debt/EBITDA 2.02
Cap/Depr 169.65%
Cap/Sales 8.69%
Interest Coverage 1.58
Cash Conversion 70.2%
Profit Quality N/A
Current Ratio 1.05
Quick Ratio 1.05
Altman-Z 0.36
F-Score4
WACC10.43%
ROIC/WACC0.55
Cap/Depr(3y)102.56%
Cap/Depr(5y)111.15%
Cap/Sales(3y)6%
Cap/Sales(5y)6.99%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-20.21%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%448.69%
EPS Next Y10.26%
EPS Next 2Y15.47%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)0.65%
Revenue growth 3Y8.26%
Revenue growth 5Y10.34%
Sales Q2Q%-2.21%
Revenue Next Year4.01%
Revenue Next 2Y3.93%
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y-16.72%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year141.18%
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y-106.13%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-21.88%
OCF growth 3Y52.41%
OCF growth 5YN/A

HIPAY GROUP SA / ALHYP.PA Fundamental Analysis FAQ

What is the ChartMill fundamental rating of HIPAY GROUP SA (ALHYP.PA) stock?

ChartMill assigns a fundamental rating of 3 / 10 to ALHYP.PA.


What is the valuation status for ALHYP stock?

ChartMill assigns a valuation rating of 5 / 10 to HIPAY GROUP SA (ALHYP.PA). This can be considered as Fairly Valued.


How profitable is HIPAY GROUP SA (ALHYP.PA) stock?

HIPAY GROUP SA (ALHYP.PA) has a profitability rating of 4 / 10.


Can you provide the financial health for ALHYP stock?

The financial health rating of HIPAY GROUP SA (ALHYP.PA) is 3 / 10.